BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 35469174)

  • 1. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics.
    Wang S; Lei B; Zhang E; Gong P; Gu J; He L; Han L; Yuan Z
    Int J Nanomedicine; 2022; 17():1757-1781. PubMed ID: 35469174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials.
    Lotfy A; AboQuella NM; Wang H
    Stem Cell Res Ther; 2023 Apr; 14(1):66. PubMed ID: 37024925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.
    Shen Z; Huang W; Liu J; Tian J; Wang S; Rui K
    Front Immunol; 2021; 12():749192. PubMed ID: 34646275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis.
    Cosenza S; Toupet K; Maumus M; Luz-Crawford P; Blanc-Brude O; Jorgensen C; Noël D
    Theranostics; 2018; 8(5):1399-1410. PubMed ID: 29507629
    [No Abstract]   [Full Text] [Related]  

  • 5. The Use of Mesenchymal Stem Cells and their Derived Extracellular Vesicles in Cardiovascular Disease Treatment.
    Khoei SG; Dermani FK; Malih S; Fayazi N; Sheykhhasan M
    Curr Stem Cell Res Ther; 2020; 15(7):623-638. PubMed ID: 32357818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.
    Liu H; Li R; Liu T; Yang L; Yin G; Xie Q
    Front Immunol; 2020; 11():1912. PubMed ID: 32973792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis.
    Zhu Y; Wang Y; Zhao B; Niu X; Hu B; Li Q; Zhang J; Ding J; Chen Y; Wang Y
    Stem Cell Res Ther; 2017 Mar; 8(1):64. PubMed ID: 28279188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation.
    Xin L; Lin X; Zhou F; Li C; Wang X; Yu H; Pan Y; Fei H; Ma L; Zhang S
    Acta Biomater; 2020 Sep; 113():252-266. PubMed ID: 32574858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases.
    Yuan YG; Wang JL; Zhang YX; Li L; Reza AMMT; Gurunathan S
    Int J Nanomedicine; 2023; 18():3177-3210. PubMed ID: 37337578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis
    Tian J; Zhu Q; Zhang Y; Bian Q; Hong Y; Shen Z; Xu H; Rui K; Yin K; Wang S
    Front Immunol; 2020; 11():598322. PubMed ID: 33362781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.
    Cosenza S; Ruiz M; Maumus M; Jorgensen C; Noël D
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions.
    Jahangiri B; Khalaj-Kondori M; Asadollahi E; Kian Saei A; Sadeghizadeh M
    J Cell Commun Signal; 2023 Dec; 17(4):1229-1247. PubMed ID: 37973719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases.
    Harrell CR; Djonov V; Antonijevic A; Volarevic V
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress of mesenchymal stem cell-derived exosomes in the treatment of inflammatory bowel disease].
    Song D; Hou K; Du Y; Zhou Y; Chu C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Feb; 39(2):186-190. PubMed ID: 36872439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases.
    Liu H; Chen Y; Yin G; Xie Q
    Life Sci; 2021 Jul; 277():119458. PubMed ID: 33831424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
    Kahmini FR; Shahgaldi S
    Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.
    Gemayel J; Chaker D; El Hachem G; Mhanna M; Salemeh R; Hanna C; Harb F; Ibrahim A; Chebly A; Khalil C
    Clin Transl Oncol; 2023 Jul; 25(7):2056-2068. PubMed ID: 36808392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases.
    Harrell CR; Volarevic V; Djonov V; Volarevic A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy.
    Jafarinia M; Alsahebfosoul F; Salehi H; Eskandari N; Ganjalikhani-Hakemi M
    Immunol Invest; 2020 Oct; 49(7):758-780. PubMed ID: 32009478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.
    Zheng G; Huang R; Qiu G; Ge M; Wang J; Shu Q; Xu J
    Cell Tissue Res; 2018 Oct; 374(1):1-15. PubMed ID: 29955951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.